Showing results (11-20 of 35) with videos related to
Sort By:
Pageof 4
American Journal of Clinical Pathology|August 1, 1991
Expression of haptoglobin-related protein in primary and metastatic breast cancers. A longitudinal study of 48 fatal tumorsM S Shurbaji, G R Pasternack, F P KuhajdaThe Journal of Biological Chemistry|August 5, 1990
Identification and preliminary characterization of two related proliferation-associated nuclear phosphoproteinsS N Malek, A I Katumuluwa, G R PasternackOncogene|May 22, 2001
Tumor suppression and potentiation by manipulation of pp32 expressionJ Bai, J R Brody, S S Kadkol, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1977
Antibody-mediated suppression of tumor growth. III. Molecular assay of murine IgG1 alloantibody required to cause tumor suppression in vivoR J Johnson, G R Pasternack, B E Drysdale, et al.The Journal of Biological Chemistry|March 25, 1985
Interactions between protein 4.1 and band 3. An alternative binding site for an element of the membrane skeletonG R Pasternack, R A Anderson, T L Leto, et al.American Journal of Clinical Pathology|May 1, 1992
Expression of oncogenic antigen 519 (OA-519) in prostate cancer is a potential prognostic indicatorM S Shurbaji, F P Kuhajda, G R Pasternack, et al.Cancer Research|February 15, 1996
Fatty acid synthase (FAS): a target for cytotoxic antimetabolites in HL60 promyelocytic leukemia cellsE S Pizer, F D Wood, G R Pasternack, et al.International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|January 1, 1997
Expression of fatty acid synthase is closely linked to proliferation and stromal decidualization in cycling endometriumE S Pizer, R J Kurman, G R Pasternack, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinomaL Z Milgraum, L A Witters, G R Pasternack, et al.Nature Medicine|March 23, 1999
Modulation of oncogenic potential by alternative gene use in human prostate cancerS S Kadkol, J R Brody, J Pevsner, et al.Pageof 4